Rocket Doctor AI sets Sept. 14 town hall to outline Q2 and 2026 growth plans

Rocket Doctor AI will host a global company town hall on Sept. 14 to review Q2 2026 operating results and outline its growth strategy in the U.S. and Canada. The virtual event is aimed at employees, investors, partners and other stakeholders as the company pushes deeper into AI-powered digital health.

Why it matters: - Rocket Doctor AI is using the town hall to signal where it wants to go next in 2026. - The event will give investors and partners a look at the company’s operating progress and near-term expansion plans. - The company is positioning its AI healthcare platform around broader access, physician support and virtual care scale.

What happened: - Rocket Doctor AI said it will host a company town hall on Monday, Sept. 14, 2026. - The virtual event will be co-led by CEO Dr. Essam Hamza and Dr. William Cherniak, founder and CEO of Rocket Doctor Inc. - The session will review Q2 2026 operational highlights and present the company’s growth strategy for the United States and Canada for the rest of 2026. - The town hall is open to team members, key stakeholders, investors and strategic partners. - The company listed the event as a Zoom webinar: Zoom Webinar. - Rocket Doctor AI also provided an in-depth profile through B2i Digital: Company profile.

The details: - The town hall is scheduled for 1 p.m. Pacific time and 4 p.m. Eastern time. - Rocket Doctor AI trades on the CSE under AIDR, OTC under AIRDF and Frankfurt under 939. - The company describes itself as a physician-built, AI-powered healthcare technology company. - Rocket Doctor AI’s Global Library of Medicine is a clinically validated decision support system developed with input from hundreds of physicians worldwide. - Rocket Doctor Inc.’s digital health platform and marketplace has helped empower more than 350 physicians to provide care for more than 750,000 patient visits. - The company says its software helps doctors launch and manage virtual or hybrid in-person practices independently. - Rocket Doctor AI says the platform reduces administrative burden, improves care consistency and creates more time for physician-patient interaction. - The company says it is focused on underserved, rural and remote communities in Canada and on patients on Medicaid and Medicare in the United States. - Rocket Doctor AI says it uses advanced AI, large language models and connected medical devices in its products. - The company’s contact page is listed at rocketdoctor.ai.

Between the lines: - The town hall appears aimed at reinforcing investor confidence ahead of the back half of 2026. - By pairing operational updates with strategy, Rocket Doctor AI is trying to show both traction and a path to scale. - The emphasis on physician autonomy and access to care suggests the company is pitching both a healthcare mission and a technology story.

What's next: - Rocket Doctor AI is expected to use the Sept. 14 event to expand on execution plans for the U.S. and Canadian markets. - The company may also use the session to frame what Q2 performance means for the rest of 2026. - Forward-looking statements in the release note that actual results could differ from management’s expectations.